Donna Lancaster - Concepedia

Author

Donna Lancaster

Royal Marsden NHS Foundation Trust

Also Known As

D Lancaster, D. Lancaster, D. R. Lancaster ,, Donna Lancaster, Lancaster D.

Publications

839

Citations

H-Index

Concepts

All Affiliations

Royal Marsden NHS Foundation Trust Royal Marsden Hospital University College London Great Ormond Street Hospital Birmingham Children's Hospital

About

Donna Lancaster is an author at Royal Marsden NHS Foundation Trust specializing in medicine, hematology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	270
2	Public Health	1	1	22
3	Blood Transplantation	1	1	128
4	Health Policy	1	1	22
5	Immunology	1	1	128

Donna Lancaster

Publications

767

Citations

H-Index

Page 1

	Year	Citations
Outcome after first relapse in childhood acute lymphoblastic leukaemia – lessons from the United Kingdom R2 trial Anindita Roy, Anna Cargill, Sharon Love, British Journal of Haematology Mixed-phenotype Acute LeukemiaImmunologyFirst RelapseImmunotherapyHematological Malignancy	2005	128
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial Lia Gore, Pamela Kearns, Maria Lucia de Martino, Journal of Clinical Oncology	2018	97
Profile of non-compliance in lymphoblastic leukaemia Donna Lancaster, Lynne Lennard, J S Lilleyman Archives of Disease in Childhood Drug SafetyLymphoblastic LeukaemiaHematological MalignancyMedicineMalignant Blood Disorder	1997	60
Dosimetry for Fractionated <sup>131</sup> I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results Susan Buckley, Frank Saran, Mark N. Gaze, Cancer Biotherapy and Radiopharmaceuticals	2007	58
Defibrotide in the prevention and treatment of veno‐occlusive disease in autologous and allogeneic stem cell transplantation in children Amrana Qureshi, Lynley V. Marshall, Donna Lancaster Pediatric Blood & Cancer	2008	58
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL Angus Hodder, Avijeet Kumar Mishra, Amir Enshaei, Journal of Clinical Oncology	2023	53
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion Anthony V. Moorman, Claire Schwab, Emily Winterman, British Journal of Haematology	2020	47
Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia Donna Lancaster, Nishith Patel, Lynne Lennard, Cancer Chemotherapy and Pharmacology Hematological MalignancyAcute Lymphoblastic LeukaemiaLaboratory HematologyPediatric HematologyMalignant Blood Disorder	2002	43
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma Sally L. George, Nadia Falzone, Sarah Chittenden, Nuclear Medicine Communications	2016	43
Familial T-cell non-Hodgkin lymphoma caused by biallelic <i>MSH2</i> mutations Richard H. Scott, Tessa Homfray, Sally G. Mitton, Journal of Medical Genetics	2007	42

Page 1